Stress incontinence (female) (male)
Methodology & AI Transparency ⓘ
Stress incontinence (female) (male) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Under Prostate (BPH), Bladder & Urinary Tract diagnostic criteria (N39.3), workup for Stress incontinence (female) (male) integrates IPSS symptom scoring [Stress incontinence (female) (male) N39.3] with evidence-graded therapy tailored to IPSS Urinary Symptom in Stress incontinence (female) (male) (N39.3: Score) response.
- 2 Real-world patient consensus: Federal ICD-10-CM code N39.3 categorizes Stress incontinence (female) (male) under Prostate (BPH), Bladder & Urinary Tract.
- 3 Typical cash cost range: Clinicians assessing Stress incontinence (female) (male) focus on prostatic fibromuscular stromal in Stress incontinence (female) (male) (N39.3: hyperplasia) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Stress incontinence (female) (male): IPSS Urinary Symptom in Stress incontinence (female) (male) (N39.3: Score) (0 – 7 (mild symptoms) (N39.3)) and Urinalysis & Post-Void in Stress incontinence (female) (male) (N39.3: Residual (PVR)).
Ask our AI Specialists anything about Stress incontinence (female) (male)
What Is Stress incontinence (female) (male)?
Under Prostate (BPH), Bladder & Urinary Tract diagnostic criteria (N39.3), workup for Stress incontinence (female) (male) integrates IPSS symptom scoring [Stress incontinence (female) (male) N39.3] with evidence-graded therapy tailored to IPSS Urinary Symptom in Stress incontinence (female) (male) (N39.3: Score) response.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Stress incontinence (female) (male) (ICD-10 N39.3) is driven by prostatic fibromuscular stromal in Stress incontinence (female) (male) (N39.3: hyperplasia); specialists in Prostate (BPH), Bladder & Urinary Tract monitor Urinalysis & Post-Void in Stress incontinence (female) (male) (N39.3: Residual (PVR)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Stress incontinence (female) (male) (N39.3): weak, hesitant, or in Stress incontinence (female) (male) (N39.3: intermittent urinary stream)
- • Secondary Stress incontinence (female) (male) clinical sign: waking two or in Stress incontinence (female) (male) (N39.3: more times nightly)
- • Symptom flares in Stress incontinence (female) (male) correlating with IPSS Urinary Symptom in Stress incontinence (female) (male) (N39.3: Score) deviation outside 0 – 7 (mild symptoms) (N39.3)
- • Functional urology & prostate impact requiring IPSS symptom scoring [Stress incontinence (female) (male) N39.3] evaluation (N39.3)
Stress incontinence (female) (male) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N39.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Prostate (BPH), Bladder & Urinary Tract | NLM Clinical Tables |
| Diagnostic / Lab Marker: IPSS Urinary Symptom in Stress incontinence (female) (male) (N39.3: Score) | 0 – 7 (mild symptoms) (N39.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urinalysis & Post-Void in Stress incontinence (female) (male) (N39.3: Residual (PVR)) | Negative leukocyte/nitrite; PVR < 50 mL (N39.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Total PSA & in Stress incontinence (female) (male) (N39.3: Serum Creatinine/eGFR) | Age-specific PSA; eGFR > 75 mL/min (N39.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Stress incontinence (female) (male)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Imipramine Pamoate Tofranil-PM • RxCUI 835591 | Tricyclic Antidepressant | 92% | $3.0066 | $ 75.44 /mo |
| Naltrexone Hydrochloride and Bupropion Hydrochloride Contrave • RxCUI RXN-51267890-3095 | Aminoketone | 83% | $1.2643 | $ 59.70 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Stress incontinence (female) (male))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic: What a 1,522-Participant Study Found Although PTSD was associated with poorer overall outcomes, the presence of concurrent PTSD among Veterans in this trial did not affect the comparative effectiveness of medications on response, full symptom relief, or relapse... The Journal of clinical psychiatry • 2020-06-23 • Randomized Controlled Trial | N = 1,522 | 90/100 | PMID 32603560 ↗ |
| New Insights on Lumateperone as add-on treatment in Patients With depression and Anxious: What a 239-Participant Study Found Conclusion: Adjunctive lumateperone 42 mg significantly improved depression and anxiety symptoms in patients with MDD with inadequate ADT response and anxious distress. The Journal of clinical psychiatry • 2026-09-14 • Phase III Randomized Trial | N = 239 | 88/100 | PMID 42752587 ↗ |
| Can This Approach Help? Inside the Latest Research on Whey Protein Supplementation on Muscle Damage, liver Stress, and Inflammatory The results highlight whey protein's potential as a nutritional aid to promote recovery and physiological adaptation, possibly mediated by antioxidant and anti-inflammatory mechanisms. European journal of sport science • 2026-11-15 • Randomized Controlled Trial | N = 30 | 88/100 | PMID 42929456 ↗ |
| Can This Approach Help? Inside the Latest Research on Self-compassion mediates treatment effects in MDMA-assisted therapy for Conclusions: These findings suggest that self-compassion may play a critical role in the therapeutic effects of MDMA-AT. European journal of psychotraumatology • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40331914 ↗ |
| Can This Approach Help? Inside the Latest Research on Influence of pravastatin and atorvastatin on markers of oxidative stress in This study suggests that statin therapy results in variable effects on oxidative stress markers in hypercholesterolemic subjects. Journal of the American College of Cardiology • 2008-04-29 • Randomized Controlled Trial | N = 120 | 88/100 | PMID 18436117 ↗ |
Stress incontinence (female) (male) Patient Community & “People Like Me” Threads
Filter Stress incontinence (female) (male) community threads and patient logs by age, biological sex, dosage, and treatment duration.